"At UCSF Health, we're taking every precaution to keep you safe and healthy during the COVID-19 pandemic. For our outpatients, we offer video visits and virtual care for hundreds of conditions as well as for primary care, mental health services, medication monitoring and more. In our hospitals, we test every patient admitted and before most procedures. Our staff wears face masks and practices rigorous hand hygiene, as well as many other methods of infection prevention. Before entering your room, they'll make sure you're masked and (in UCSF Benioff Children's Hospitals) that your child age 2+ is masked. If you're planning to visit someone in the hospital, be sure to check our COVID-19 visitor restrictions before going."

During the past decade, Ucsf Hiv/Aids Crs conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 8 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 3 clinical trials were completed. i.e. 30% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ucsf Hiv/Aids Crs" #1 collaborator was "ViiV Healthcare" with 3 trials as a collaborator, "AIDS Clinical Trials Group" with 2 trials as a collaborator, "Rockefeller University" with 2 trials as a collaborator, "Dynavax Technologies Corporation" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Ucsf Hiv/Aids Crs" are "HIV Infections" (17 trials), "HIV Infection" (4 trials), "Hepatitis C" (2 trials), "Tuberculosis" (2 trials) and "Cardiovascular Diseases" (1 trials). Many other conditions were trialed in "Ucsf Hiv/Aids Crs" in a lesser frequency.

Most popular intervention types in "Ucsf Hiv/Aids Crs" are "Drug" (16 trials), "Biological" (10 trials), "Dietary Supplement" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Isoniazid (INH)" (2 trials), "Pyridoxine (Vitamin B6)" (2 trials), "Ribavirin (RBV)" (2 trials) and "Rifapentine (RPT)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ucsf Hiv/Aids Crs" are 22 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Ucsf Hiv/Aids Crs". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Ucsf Hiv/Aids Crs, 3 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ucsf Hiv/Aids Crs, 7 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Ucsf Hiv/Aids Crs has several departments that took part in Clinical trials: "Multiple Sclerosis Center at UCSF" - 14 trials, "UCSF Cancer Center - San Mateo" - 9 trials, "UCSF PHP, Gen. Internal Medicine Practice CRS" - 5 trials, "University of California, San Francisco Liver Clinic" - 5 trials, "University of California, San Francisco - Outpatient Hematology Clinic" - 4 trials, "UCSF Endoscopy Unit at Mount Zion" - 3 trials, "UCSF Division of Gastroenterology at Mount Zion" - 3 trials, "UCSF Cancer Center - Berkeley" - 2 trials, "UCSF Surgical Movement Disorders Center" - 2 trials, "UCSF Emergency Deparmtent" - 2 trials, "UCSF Cardiovascular Care and Prevention Center" - 2 trials